US 8821866
Methods of treating and preventing colitis involving IL-13 and NK-T cells
granted A61KA61K2039/505A61P
Quick answer
US patent 8821866 (Methods of treating and preventing colitis involving IL-13 and NK-T cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/00, A61P1/04